The pharmaceutical manufacturer filed a Worker Adjustment and Retraining Notification with the Pennsylvania Department of ...

The pharmaceutical industry requires rapid training to address workforce shortages for new US manufacturing facilities, ...

Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to ...

Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US ...

Sun Pharma arm, Taro, recalls over 17,000 units of antifungal shampoo in the US due to manufacturing issues. USFDA report details the recall.

The Class II recall, which began on December 9, addresses potential temporary health consequences from the product.

Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection ...

CHENNAI: Taro Pharmaceutical Industries, one of the US subsidiaries of India's largest drug maker Sun Pharmaceutical Industries Ltd, has recalled more than 17,0 ...

Track key updates on Ola Electric, IndusInd Bank, NTPC, Vodafone Idea, and more in today's must-watch stock list—get the ...

Stock investors of Central Pharmaceuticals have been unsettled after the auditor of the listed drug maker issued an adverse opinion, warning of significant uncertainty over the company’s ability to ...